ATE459622T1 - Tropanverbindungen - Google Patents

Tropanverbindungen

Info

Publication number: ATE459622T1
Authority: AT; Austria
Prior art keywords: tropane compounds; tropane; compounds; formula; methods
Prior art date: 2007-10-25

Application number

AT08832769T

Other languages

English (en)

Inventor

Kenneth D Rice

Naing Aay

Arlyn Arcalas

Tae-Gon Baik

Charles M Blazey

Owen Joseph Bowles

Chris A Buhr

Joerg Bussenius

Simona Costanzo

Jeffry Kimo Curtis

Steven Charles Defina

Larisa Dubenko

Abigail R Kennedy

Angie Inyoung Kim

Katherine Lara

Sunghoon Ma

Jean-Claire Limun Manalo

Csaba J Peto

Tsze H Tsang

Longcheng Wang

Neel Kumar Anand

Original Assignee

Exelixis Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-25

Filing date

2008-10-27

Publication date

2010-03-15

2008-10-27 Application filed by Exelixis Inc filed Critical Exelixis Inc

2010-03-15 Application granted granted Critical

2010-03-15 Publication of ATE459622T1 publication Critical patent/ATE459622T1/de

Links

XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical class C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Obesity (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)

AT08832769T 2007-10-25 2008-10-27 Tropanverbindungen ATE459622T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US68707P	2007-10-25	2007-10-25
PCT/US2008/012221 WO2009055077A1 (en)	2007-10-25	2008-10-27	Tropane compounds

Publications (1)

Publication Number	Publication Date
ATE459622T1 true ATE459622T1 (de)	2010-03-15

Family

ID=40287869

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08832769T ATE459622T1 (de)	2007-10-25	2008-10-27	Tropanverbindungen

Country Status (26)

Country	Link
US (1)	US8012956B2 (de)
EP (1)	EP2074120B1 (de)
JP (2)	JP5476307B2 (de)
KR (1)	KR101578792B1 (de)
CN (1)	CN101910168B (de)
AT (1)	ATE459622T1 (de)
AU (1)	AU2008317262B2 (de)
BR (1)	BRPI0818893B8 (de)
CA (1)	CA2703477C (de)
CO (1)	CO6321232A2 (de)
CY (1)	CY1110648T1 (de)
DE (1)	DE602008000754D1 (de)
DK (1)	DK2074120T3 (de)
EA (1)	EA018999B1 (de)
ES (1)	ES2342348T3 (de)
HR (1)	HRP20100292T1 (de)
IL (1)	IL205202A0 (de)
MX (1)	MX2010004493A (de)
NZ (1)	NZ585137A (de)
PL (1)	PL2074120T3 (de)
PT (1)	PT2074120E (de)
RS (1)	RS51346B (de)
SG (1)	SG2012079653A (de)
SI (1)	SI2074120T1 (de)
WO (1)	WO2009055077A1 (de)
ZA (1)	ZA201002987B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2553340T3 (es) *	2007-12-12	2015-12-07	Rigel Pharmaceuticals, Inc.	Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
FR2949467B1 (fr)	2009-09-03	2011-11-25	Sanofi Aventis	Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
UY32940A (es)	2009-10-27	2011-05-31	Bayer Cropscience Ag	Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
EP2557082A4 (de)	2010-04-05	2013-08-28	Shionogi & Co	Cephemverbindung mit einer catecholgruppe
EP2640366A2 (de)	2010-11-15	2013-09-25	Exelixis, Inc.	Benzoxazepine als pi3k/mtor-hemmer sowie verfahren zur ihrer verwendung und herstellung
EP2740474A1 (de)	2012-12-05	2014-06-11	Instituto Europeo di Oncologia S.r.l.	Cyclopropylaminderivate als Hemmer von Histon-Demethylase-KDM1A
WO2014107718A2 (en) *	2013-01-07	2014-07-10	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Heat shock protein (hsp) inhibition and monitoring effectiveness thereof
PH12021550330A1 (en)	2013-08-21	2022-09-28	Janssen Biopharma Inc	Antiviral compounds
AU2014348232A1 (en) *	2013-11-18	2016-06-30	Del Mar Pharmaceuticals	HPLC analysis of impurities in dianhydrogalactitol
AU2015265820C1 (en)	2014-05-30	2020-01-16	Ieo - Istituto Europeo Di Oncologia S.R.L.	Cyclopropylamine compounds as histone demethylase inhibitors
EP2949648A1 (de)	2014-05-30	2015-12-02	IEO - Istituto Europeo di Oncologia Srl	Cyclopropylaminderivate als Histondemethylaseinhibitoren
US20170224670A1 (en)	2014-10-14	2017-08-10	Exelixis, Inc.	Drug Combination to Treat Melanoma
US20180200392A1 (en) *	2015-07-16	2018-07-19	Akuru Pharma Ab	Detection and treatment of renal cell carcinoma with a slc6a3 ligand linked to a label, cytotoxic or immunomodulatory group
WO2018155260A1 (ja) *	2017-02-23	2018-08-30	株式会社Ihi	Ｏｈラジカル検出プローブ、ｏｈラジカル測定装置、および、ｏｈラジカル測定方法
CN108164529B (zh) *	2017-12-25	2020-04-24	三峡大学	一种小分子抑制剂sld9059及其在制药中的应用
US11466012B2 (en)	2018-01-10	2022-10-11	Allinky Biopharma	Tetrahydroisoquinoline compounds
WO2020206608A1 (en)	2019-04-09	2020-10-15	Ranok Therapeutics (Hangzhou) Co., Ltd.	Methods and compositions for targeted protein degradation
CN111825702A (zh) *	2019-04-22	2020-10-27	成都科岭源医药技术有限公司	一种氮杂*并吲唑类衍生物及其制备方法和用途
CN110698395B (zh) *	2019-10-22	2021-05-25	杭州百诚医药科技股份有限公司	一种托吡司特的中间体的制备方法
CN112920078A (zh) *	2019-12-05	2021-06-08	武汉珈汇精化科技有限公司	一种制备4-氰基苯甲酸甲酯的方法和一种制备4-氰基苯甲酸的方法
TW202136238A (zh) *	2020-01-06	2021-10-01	大陸商廣東東陽光藥業有限公司	RORγt抑制劑及其製備方法和用途
IL302081A (en) *	2020-10-14	2023-06-01	Ranok Therapeutics Hangzhou Co Ltd	Methods and compositions for targeted protein degradation
CN114591192B (zh) *	2020-12-04	2024-06-21	江西仰立新材料有限公司	一种n-环丙甲基苯胺类化合物的制备方法
US20240083910A1 (en) *	2020-12-18	2024-03-14	Merck Sharp & Dohme Llc	Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses
CN112707809B (zh) *	2020-12-30	2023-08-29	丽珠集团新北江制药股份有限公司	一种制备噁唑啉杀虫剂氟雷拉纳中间体的方法
CA3226271A1 (en) *	2021-07-26	2023-02-02	Zoetis Services Llc	Serotonin 5-ht2b inhibitory compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0101641A3 (de)	1982-07-22	1984-03-28	Beecham Group Plc	Sulphonylamino-aza-bicycloalkyl-Derivate
FR2738569B1 (fr) *	1995-09-12	1997-11-28	Pf Medicament	Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
ZA97288B (en)	1996-01-15	1998-07-14	Janssen Pharmaceutica Nv	Angiogenesis inhibiting pyridazinamines
HUP0202001A2 (hu) *	2002-06-14	2005-08-29	Sanofi-Aventis	DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
ATE435862T1 (de)	2003-05-28	2009-07-15	Theravance Inc	Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
UA82517C2 (uk) *	2003-06-24	2008-04-25	Ньюросерч А/С	Нові похідні 8-аза-біцикло[3.2.1]октану та їх застосування як інгібіторів ресорбції моноамінових медіаторів
MXPA06003749A (es)	2003-10-03	2006-06-14	Pfizer	Derivados de tropano.
GB0323236D0 (en) *	2003-10-03	2003-11-05	Pfizer Ltd	Chemical compounds
JP4804346B2 (ja) *	2004-03-31	2011-11-02	日本曹達株式会社	環状アミン化合物および有害生物防除剤
FR2873693B1 (fr) *	2004-07-29	2006-09-15	Sanofi Synthelabo	Derives d'amino-tropane, leur preparation et leur application en therapeutique
WO2006075004A2 (en)	2005-01-13	2006-07-20	Neurosearch A/S	3, 8 - substituted 8-aza-bicyclo[3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN102127078A (zh) *	2005-07-14	2011-07-20	安斯泰来制药株式会社	Janus激酶3的杂环类抑制剂
NZ567127A (en) *	2005-10-06	2010-04-30	Nippon Soda Co	Bridged cyclic amine compound and pest control agent
BRPI0716240B8 (pt) *	2006-09-01	2019-09-17	Oat Agrio Co Ltd	composto de n-piridilpiperidina, método para a sua produção, e agente de controle de pestes

2008
- 2008-10-27 RS RSP-2010/0220A patent/RS51346B/sr unknown
- 2008-10-27 US US12/290,159 patent/US8012956B2/en active Active
- 2008-10-27 ES ES08832769T patent/ES2342348T3/es active Active
- 2008-10-27 MX MX2010004493A patent/MX2010004493A/es active IP Right Grant
- 2008-10-27 SI SI200830024T patent/SI2074120T1/sl unknown
- 2008-10-27 PL PL08832769T patent/PL2074120T3/pl unknown
- 2008-10-27 KR KR1020107011444A patent/KR101578792B1/ko not_active Expired - Fee Related
- 2008-10-27 BR BRPI0818893A patent/BRPI0818893B8/pt not_active IP Right Cessation
- 2008-10-27 AU AU2008317262A patent/AU2008317262B2/en not_active Ceased
- 2008-10-27 DE DE602008000754T patent/DE602008000754D1/de active Active
- 2008-10-27 HR HR20100292T patent/HRP20100292T1/hr unknown
- 2008-10-27 DK DK08832769.7T patent/DK2074120T3/da active
- 2008-10-27 CN CN200880122860.5A patent/CN101910168B/zh not_active Expired - Fee Related
- 2008-10-27 EA EA201070519A patent/EA018999B1/ru not_active IP Right Cessation
- 2008-10-27 SG SG2012079653A patent/SG2012079653A/en unknown
- 2008-10-27 NZ NZ585137A patent/NZ585137A/en not_active IP Right Cessation
- 2008-10-27 AT AT08832769T patent/ATE459622T1/de active
- 2008-10-27 PT PT08832769T patent/PT2074120E/pt unknown
- 2008-10-27 WO PCT/US2008/012221 patent/WO2009055077A1/en not_active Ceased
- 2008-10-27 JP JP2010531069A patent/JP5476307B2/ja not_active Expired - Fee Related
- 2008-10-27 EP EP08832769A patent/EP2074120B1/de active Active
- 2008-10-27 CA CA2703477A patent/CA2703477C/en active Active
2010
- 2010-04-19 IL IL205202A patent/IL205202A0/en active IP Right Grant
- 2010-04-29 ZA ZA2010/02987A patent/ZA201002987B/en unknown
- 2010-05-24 CO CO10061824A patent/CO6321232A2/es not_active Application Discontinuation
- 2010-06-01 CY CY20101100483T patent/CY1110648T1/el unknown
2013
- 2013-12-13 JP JP2013257559A patent/JP5745021B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2008317262A1 (en)	2009-04-30
BRPI0818893A2 (pt)	2015-05-05
JP2014070077A (ja)	2014-04-21
RS51346B (sr)	2011-02-28
EA018999B1 (ru)	2013-12-30
ZA201002987B (en)	2011-02-23
CA2703477A1 (en)	2009-04-30
HRP20100292T1 (hr)	2010-06-30
CN101910168A (zh)	2010-12-08
DK2074120T3 (da)	2010-06-14
PL2074120T3 (pl)	2010-08-31
EA201070519A1 (ru)	2010-12-30
SI2074120T1 (sl)	2010-06-30
JP5476307B2 (ja)	2014-04-23
IL205202A0 (en)	2010-12-30
PT2074120E (pt)	2010-06-15
JP2011500815A (ja)	2011-01-06
MX2010004493A (es)	2010-06-11
AU2008317262B2 (en)	2013-12-19
ES2342348T3 (es)	2010-07-05
JP5745021B2 (ja)	2015-07-08
BRPI0818893B8 (pt)	2021-05-25
EP2074120B1 (de)	2010-03-03
CA2703477C (en)	2016-10-11
NZ585137A (en)	2012-07-27
US8012956B2 (en)	2011-09-06
CN101910168B (zh)	2014-07-30
DE602008000754D1 (de)	2010-04-15
KR20100090782A (ko)	2010-08-17
SG2012079653A (en)	2014-05-29
EP2074120A1 (de)	2009-07-01
CO6321232A2 (es)	2011-09-20
WO2009055077A1 (en)	2009-04-30
KR101578792B1 (ko)	2015-12-21
CY1110648T1 (el)	2015-06-10
HK1129390A1 (en)	2009-11-27
US20090163471A1 (en)	2009-06-25
BRPI0818893B1 (pt)	2021-02-02

Legal Events

Date

Code

Title

Description

2010-10-15

UEP

Publication of translation of european patent specification

Ref document number: 2074120

Country of ref document: EP

Publication	Publication Date	Title
DK2074120T3 (da)	2010-06-14	Tropan-forbindelser
EA201100037A1 (ru)	2011-08-30	Органические соединения
EA201270254A1 (ru)	2012-07-30	Производные 5-фторпиримидинона
EA201070786A1 (ru)	2011-02-28	Бензофуропиримидиноны
UA107445C2 (uk)	2015-01-12	5-фторпіримідинові похідні як фунгіциди
SMP201100019B (it)	2012-01-18	Composti organici
EA201201377A1 (ru)	2013-04-30	Определенные аминопиридазины, композиции на их основе и способы их использования
MA32383B1 (fr)	2011-06-01	DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
BR112012018345A2 (pt)	2018-07-10	"compostos de heteroarila, bem como composições e usos dos mesmos"
CY1118199T1 (el)	2017-06-28	Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
WO2010003133A3 (en)	2010-03-18	Cdk modulators
UA108101C2 (xx)	2015-03-25	Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201270257A1 (ru)	2012-08-30	Производные n1-сульфонил-5-фторпиримидинона
MY146638A (en)	2012-09-14	Insecticidal aryl isoxazoline derivatives
PH12012501905A1 (en)	2015-10-19	Quinoline derivatives and their use as fungicides
ATE554066T1 (de)	2012-05-15	Entzündungshemmende substituierte cyclobutendionverbindungen
MX2012008141A (es)	2012-08-03	Compuestos y metodos.
UA106889C2 (uk)	2014-10-27	Похідні n1-ацил-5-фторпіримідинону
EA201270256A1 (ru)	2012-07-30	Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
NO20085317L (no)	2009-02-05	Imidazoazepinonforbindelser
EP2585446A4 (de)	2013-12-25	Verbindungen mit antagonistischer wirkung gegen trpv1 und ihre verwendung
ATE481395T1 (de)	2010-10-15	Cyclohexylderivate
ATE533477T1 (de)	2011-12-15	Pharmazeutische zusammensetzungen enthaltend irbesartan
UY30235A1 (es)	2007-10-31	Inhibidores de la adenilato ciclasa soluble
NZ590367A (en)	2012-08-31	9-Substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials